Ney Carter Borges on Colchicine As 2ry Prevention in Atherosclerotic CVD
Ney Carter Borges, Member Cardiologist of Global Physician Association at Cleveland Clinic Florida, shared on LinkedIn:
”Low-dose colchicine (0.5 mg/day) has emerged as an effective anti-inflammatory strategy for secondary prevention in atherosclerotic cardiovascular disease.
By inhibiting microtubule assembly, colchicine suppresses activation of the NLRP3 inflammasome, leading to reduced interleukin-1β and interleukin-6 signaling, key drivers of plaque inflammation and instability.
Clinical trial data demonstrate that colchicine significantly stabilizes atherosclerotic plaques, attenuates neutrophil activation, and reduces thrombogenic potential.
A pooled analysis of randomized trials shows a 25% relative reduction in major adverse cardiovascular events (HR ~0.75), with consistent reductions in myocardial infarction (≈23%), ischemic stroke (≈22%), and cardiovascular mortality (≈34%).
These benefits occur without an increase in non-cardiovascular mortality and with good tolerability in most patients.
Taken together, these findings position colchicine as a third pillar of secondary prevention, complementing lipid-lowering and antithrombotic therapies by targeting residual inflammatory risk in patients with established atherosclerosis.”
Stay updated with Hemostasis Today.
-
Sep 14, 2026, 20:48Valerie Dehondt: Nutritional Anemia Is Associated With Increased Risk of Severe COPD Exacerbations
-
Sep 14, 2026, 20:46Nupur Choudhury: Exploring AI-Based Detection of Anemia Using Eye and Fingernail Images
-
Sep 14, 2026, 20:44Shamee Shastry: Chart Before You Chase – Diagnosing Drug-Induced Hemolytic Anemia
-
Sep 14, 2026, 20:43David Reiner: Blood Tests That Can Reveal Nutrition Clues
-
Sep 14, 2026, 20:40Giuseppe Biondi Zoccai: Balancing Thrombosis and Bleeding in Acute MI With Hemophilia A
-
Sep 14, 2026, 20:39Kemal Karaagac: Kounis Syndrome as a Possible Cause of Very Late Stent Thrombosis
-
Sep 14, 2026, 20:38Mirvat Alasnag: IVUS and OCT Guided PCI Reduce MACE, Revascularization and Stent Thrombosis
-
Sep 14, 2026, 16:14Susanne Lager: Isthmin-2 Emerges as an Early Predictor of Pregnancy Complications
-
Sep 14, 2026, 15:53Leonard Valentino: Advancing a New Model of Patient-Led Research